Manipulation of costimulatory molecules by intracellular pathogens: Veni, Vidi, Vici!!

PLoS Pathogens

Volumn 8, Issue 6, 2012, Pages

  Khan, Nargis ^a   Gowthaman, Uthaman ^a   Pahari, Susanta ^a   Agrewala, Javed N ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD69 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNINDEXED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; LEISHMANIA DONOVANI; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL; T LYMPHOCYTE; ANIMAL; BACTERIAL INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; VIRUS INFECTION;

LEISHMANIA DONOVANI; LEISHMANIA SP.; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; ANTIGEN PRESENTATION; BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 84864075069     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002676     Document Type: Review

References (107)

1. Finlay BB, McFadden G, (2006) Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124: 767-782.
2. Curtsinger JM, Mescher MF, (2010) Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol 22: 333-340.
3. Jenkins MK, (1994) The ups and downs of T cell costimulation. Immunity 1: 443-446.
4. Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN, (2002) Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem 277: 7766-7775.
5. Gowthaman U, Chodisetti SB, Agrewala JN, (2010) T cell help to B cells in germinal centers: putting the jigsaw together. Int Rev Immunol 29: 403-420.
6. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, et al. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184: 747-752.
7. Orabona C, Grohmann U, Belladonna ML, Fallarino F, Vacca C, et al. (2004) CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat Immunol 5: 1134-1142.
8. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, et al. (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12: 881-922.
9. De Keersmaecker B, Heirman C, Corthals J, Empsen C, van Grunsven LA, et al. (2011) The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses. J Leukoc Biol 89: 989-999.
10. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, et al. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405-413.
11. Keir ME, Butte MJ, Freeman GJ, Sharpe AH, (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26: 677-704.
12. Krutzik SR, Sieling PA, Modlin RL, (2001) The role of Toll-like receptors in host defense against microbial infection. Curr Opin Immunol 13: 104-108.
13. Cooper AM, (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27: 393-422.
14. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, et al. (1995) CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98.
15. Grewal IS, Flavell RA, (1996) The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 153: 85-106.
16. Schreiber HA, Hulseberg PD, Lee J, Prechl J, Barta P, et al. (2010) Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. PLoS One 5: e11453 doi:10.1371/journal.pone.0011453.
17. Bonato VL, Medeiros AI, Lima VM, Dias AR, Faccioliti LH, et al. (2001) Downmodulation of CD18 and CD86 on macrophages and VLA-4 on lymphocytes in experimental tuberculosis. Scand J Immunol 54: 564-573.
18. Pecora ND, Fulton SA, Reba SM, Drage MG, Simmons DP, et al. (2009) Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Cell Immunol 254: 94-104.
19. Henderson RA, Watkins SC, Flynn JL, (1997) Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 159: 635-643.
20. Saha B, Das G, Vohra H, Ganguly NK, Mishra GC, (1994) Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Eur J Immunol 24: 2618-2624.
21. Agrewala JN, Kumar B, Vohra H, (1998) Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy. Clin Exp Immunol 111: 56-63.
22. Fuse S, Zhang W, Usherwood EJ, (2008) Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J Immunol 180: 1148-1157.
23. Bhatt K, Uzelac A, Mathur S, McBride A, Potian J, et al. (2009) B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection. J Immunol 182: 3793-3800.
24. Herold KC, Lu J, Rulifson I, Vezys V, Taub D, et al. (1997) Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J Immunol 159: 4150-4153.
25. Arias MA, Jaramillo G, Lopez YP, Mejia N, Mejia C, et al. (2007) Mycobacterium tuberculosis antigens specifically modulate CCR2 and MCP-1/CCL2 on lymphoid cells from human pulmonary hilar lymph nodes. J Immunol 179: 8381-8391.
26. Kan-Sutton C, Jagannath C, Hunter RL Jr, (2009) Trehalose 6,6′-dimycolate on the surface of Mycobacterium tuberculosis modulates surface marker expression for antigen presentation and costimulation in murine macrophages. Microbes Infect 11: 40-48.
27. Singh B, Singh G, Trajkovic V, Sharma P, (2003) Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7.1 expression and nitric oxide release. Clin Exp Immunol 134: 70-77.
28. Grewal IS, Borrow P, Pamer EG, Oldstone MB, Flavell RA, (1997) The CD40-CD154 system in anti-infective host defense. Curr Opin Immunol 9: 491-497.
29. Yamauchi PS, Bleharski JR, Uyemura K, Kim J, Sieling PA, et al. (2000) A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy. J Immunol 165: 1506-1512.
30. Murray RA, Siddiqui MR, Mendillo M, Krahenbuhl J, Kaplan G, (2007) Mycobacterium leprae inhibits dendritic cell activation and maturation. J Immunol 178: 338-344.
31. Samten B, Thomas EK, Gong J, Barnes PF, (2000) Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis. Infect Immun 68: 3002-3006.
32. Campos-Neto A, Ovendale P, Bement T, Koppi TA, Fanslow WC, et al. (1998) CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 160: 2037-2041.
33. Lazarevic V, Myers AJ, Scanga CA, Flynn JL, (2003) CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19: 823-835.
34. Stewart GR, Snewin VA, Walzl G, Hussell T, Tormay P, et al. (2001) Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med 7: 732-737.
35. Sakai S, Kawamura I, Okazaki T, Tsuchiya K, Uchiyama R, et al. (2010) PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guerin. Int Immunol 22: 915-925.
36. Jurado JO, Alvarez IB, Pasquinelli V, Martinez GJ, Quiroga MF, et al. (2008) Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 181: 116-125.
37. Alvarez IB, Pasquinelli V, Jurado JO, Abbate E, Musella RM, et al. (2010) Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J Infect Dis 202: 524-532.
38. Lazar-Molnar E, Chen B, Sweeney KA, Wang EJ, Liu W, et al. (2010) Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci U S A 107: 13402-13407.
39. Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A, (2010) CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J Immunol 186: 1598-1607.
40. Hanekom WA, Mendillo M, Manca C, Haslett PA, Siddiqui MR, et al. (2003) Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. J Infect Dis 188: 257-266.
41. Shortman K, Heath WR, (2001) Immunity or tolerance? That is the question for dendritic cells. Nat Immunol 2: 988-989.
42. Levings MK, Sangregorio R, Roncarolo MG, (2001) Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193: 1295-1302.
43. Anderson KM, Czinn SJ, Redline RW, Blanchard TG, (2006) Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J Immunol 176: 5306-5313.
44. Yao T, Mecsas J, Healy JI, Falkow S, Chien Y, (1999) Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med 190: 1343-1350.
45. Pryjma J, Baran J, Ernst M, Woloszyn M, Flad HD, (1994) Altered antigen-presenting capacity of human monocytes after phagocytosis of bacteria. Infect Immun 62: 1961-1967.
46. Wyant TL, Tanner MK, Sztein MB, (1999) Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells. Infect Immun 67: 1338-1346.
47. Das S, Suarez G, Beswick EJ, Sierra JC, Graham DY, et al. (2006) Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol 176: 3000-3009.
48. Beswick EJ, Pinchuk IV, Das S, Powell DW, Reyes VE, (2007) Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells. Infect Immun 75: 4334-4341.
49. Skinner JA, Reissinger A, Shen H, Yuk MH, (2004) Bordetella type III secretion and adenylate cyclase toxin synergize to drive dendritic cells into a semimature state. J Immunol 173: 1934-1940.
50. Ross PJ, Lavelle EC, Mills KH, Boyd AP, (2004) Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun 72: 1568-1579.
51. Everett H, McFadden G, (1999) Apoptosis: an innate immune response to virus infection. Trends Microbiol 7: 160-165.
52. Price DA, Klenerman P, Booth BL, Phillips RE, Sewell AK, (1999) Cytotoxic T lymphocytes, chemokines and antiviral immunity. Immunol Today 20: 212-216.
53. World Health Organization (2010) Global health observatory (GHO). Available: http://www.who.int/gho/hiv/en/index.html Accessed 5 June 2012.
54. Davis CB, Dikic I, Unutmaz D, Hill CM, Arthos J, et al. (1997) Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 186: 1793-1798.
55. Geijtenbeek TB, van Kooyk Y, (2003) DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. Curr Top Microbiol Immunol 276: 31-54.
56. Douek DC, Brenchley JM, Betts MR, Ambrozak DR, Hill BJ, et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature 417: 95-98.
57. Rowland-Jones S, (1999) HIV infection: where have all the T cells gone? Lancet 354: 5-7.
58. Kornbluth RS, (2002) An expanding role for CD40L and other tumor necrosis factor superfamily ligands in HIV infection. J Hematother Stem Cell Res 11: 787-801.
59. Smed-Sorensen A, Lore K, Walther-Jallow L, Andersson J, Spetz AL, (2004) HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 104: 2810-2817.
60. Kornbluth RS, (2000) The emerging role of CD40 ligand in HIV infection. J Leukoc Biol 68: 373-382.
61. Qiao X, He B, Chiu A, Knowles DM, Chadburn A, et al. (2006) Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol 7: 302-310.
62. Cagigi A, Nilsson A, Pensieroso S, Chiodi F, (2010) Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis 10: 499-503.
63. De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, et al. (2004) Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103: 2180-2186.
64. Boudet F, Lecoeur H, Gougeon ML, (1996) Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol 156: 2282-2293.
65. Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, et al. (1996) The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. Aids 10: 9-16.
66. Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, et al. (2011) Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J Immunol 186: 4599-4608.
67. Chaudhry A, Das SR, Hussain A, Mayor S, George A, et al. (2005) The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol 175: 4566-4574.
68. Venkatachari NJ, Majumder B, Ayyavoo V, (2007) Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function. Virology 358: 347-356.
69. De Keersmaecker B, Thielemans K, Aerts JL, (2011) Fighting with the enemy's weapons? the role of costimulatory molecules in HIV. Curr Mol Med 11: 172-196.
70. Servet-Delprat C, Vidalain PO, Bausinger H, Manie S, Le Deist F, et al. (2000) Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol 164: 1753-1760.
71. Salio M, Cella M, Suter M, Lanzavecchia A, (1999) Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 29: 3245-3253.
72. Auffermann-Gretzinger S, Keeffe EB, Levy S, (2001) Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97: 3171-3176.
73. Coscoy L, Ganem D, (2001) A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest 107: 1599-1606.
74. Wherry EJ, (2011) T cell exhaustion. Nat Immunol 12: 492-499.
75. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
76. Petrovas C, Casazza JP, Brenchley JM, Price DA, Gostick E, et al. (2006) PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 203: 2281-2292.
77. Chikuma S, Terawaki S, Hayashi T, Nabeshima R, Yoshida T, et al. (2009) PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. J Immunol 182: 6682-6689.
78. Trabattoni D, Saresella M, Biasin M, Boasso A, Piacentini L, et al. (2003) B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 101: 2514-2520.
79. Chen L, Zhang Z, Chen W, Zhang Z, Li Y, et al. (2007) B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol 178: 6634-6641.
80. Hall BF, Joiner KA, (1991) Strategies of obligate intracellular parasites for evading host defences. Immunol Today 12: A22-27.
81. Kaye PM, Rogers NJ, Curry AJ, Scott JC, (1994) Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages. Eur J Immunol 24: 2850-2854.
82. Fischer HG, Dorfler R, Schade B, Hadding U, (1999) Differential CD86/B7-2 expression and cytokine secretion induced by Toxoplasma gondii in macrophages from resistant or susceptible BALB H-2 congenic mice. Int Immunol 11: 341-349.
83. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, et al. (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4: 283-289.
84. Martin S, Agarwal R, Murugaiyan G, Saha B, (2010) CD40 expression levels modulate regulatory T cells in Leishmania donovani infection. J Immunol 185: 551-559.
85. Mukherjee P, Chauhan VS, (2008) Plasmodium falciparum-free merozoites and infected RBCs distinctly affect soluble CD40 ligand-mediated maturation of immature monocyte-derived dendritic cells. J Leukoc Biol 84: 244-254.
86. Qin H, Wilson CA, Lee SJ, Zhao X, Benveniste EN, (2005) LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood 106: 3114-3122.
87. Terawaki S, Chikuma S, Shibayama S, Hayashi T, Yoshida T, et al. (2011) IFN-alpha directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity. J Immunol 186: 2772-2779.
88. Lim W, Gee K, Mishra S, Kumar A, (2005) Regulation of B7.1 costimulatory molecule is mediated by the IFN regulatory factor-7 through the activation of JNK in lipopolysaccharide-stimulated human monocytic cells. J Immunol 175: 5690-5700.
89. Jaiswal AI, Dubey C, Swain SL, Croft M, (1996) Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. Int Immunol 8: 275-285.
90. Lenschow DJ, Walunas TL, Bluestone JA, (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14: 233-258.
91. Rub A, Dey R, Jadhav M, Kamat R, Chakkaramakkil S, et al. (2009) Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. Nat Immunol 10: 273-280.
92. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM, (1993) IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151: 1224-1234.
93. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, et al. (2003) Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197: 7-17.
94. Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S, et al. (2007) Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 8: 610-618.
95. Meier A, Bagchi A, Sidhu HK, Alter G, Suscovich TJ, et al. (2008) Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. AIDS 22: 655-658.
96. Muthumani K, Shedlock DJ, Choo DK, Fagone P, Kawalekar OU, et al. (2010) HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells. J Immunol 187: 2932-2943.
97. Chaudhry A, Das SR, Jameel S, George A, Bal V, et al. (2007) A two-pronged mechanism for HIV-1 Nef-mediated endocytosis of immune costimulatory molecules CD80 and CD86. Cell Host Microbe 1: 37-49.
98. Swigut T, Shohdy N, Skowronski J, (2001) Mechanism for down-regulation of CD28 by Nef. Embo J 20: 1593-1604.
99. Mahon RN, Rojas RE, Fulton SA, Franko JL, Harding CV, et al. (2009) Mycobacterium tuberculosis cell wall glycolipids directly inhibit CD4+ T-cell activation by interfering with proximal T-cell-receptor signaling. Infect Immun 77: 4574-4583.
100. Chirmule N, McCloskey TW, Hu R, Kalyanaraman VS, Pahwa S, (1995) HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J Immunol 155: 917-924.
101. Manninen A, Renkema GH, Saksela K, (2000) Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway. J Biol Chem 275: 16513-16517.
102. Yao ZQ, King E, Prayther D, Yin D, Moorman J, (2007) T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling. Viral Immunol 20: 276-287.
103. Leonard JP, Friedberg JW, Younes A, Fisher D, Gordon LI, et al. (2007) A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma. Ann Oncol 18: 1216-1223.
104. Agrawal A, Lingappa J, Leppla SH, Agrawal S, Jabbar A, et al. (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424: 329-334.
105. Chou PJ, Newton CA, Perkins I, Friedman H, Klein TW, (2008) Suppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function tested. DNA Cell Biol 27: 637-648.
106. Mitchell P, Germain C, Fiori PL, Khamri W, Foster GR, et al. (2007) Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun 75: 810-819.
107. Saha B, Das G, Vohra H, Ganguly NK, Mishra GC, (1995) Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity. Eur J Immunol 25: 2492-2498.